Gain Therapeutics, Inc. GANX
1.03 USD +0.07 (+7.25%)
At closeNov 6, 2026, 4:00 PM EST
1.03 -0.01 -0.49%
After hours · Nov 6, 4:00 PM ET
0.96 Day range 1.03
0.94 52-week range 4.34
- YTD
- -68.01%
- 1 year
- -45.79%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -18.71M | -20.35M | -22.25M | -17.78M | -13.83M | |
| -20.16M | -20.41M | -22.27M | -17.59M | -13.89M | |
| -0.61 | -0.89 | -1.71 | -1.48 | -1.37 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 20.84M | 10.39M | 11.79M | 7.31M | 36.88M | |
| 22.82M | 12.12M | 18.61M | 24.10M | 38.99M | |
| 4.25M | 4.78M | 6.03M | 5.22M | 4.17M | |
| 732.07K | 653.01K | 1.03M | 1.27M | 1.61M | |
| 18.56M | 7.34M | 12.58M | 18.88M | 34.82M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -18.47M | -18.87M | -18.87M | -14.69M | -12.37M | |
| 28.45M | 13.01M | 12.64M | -78.77K | 41.77M | |
| 10.46M | -1.41M | 4.49M | -29.57M | 29.41M |